The Drug Information Association (DIA) Study Endpoints Special Interest Area Community (SIAC) will host Measuring Study Endpoints in Multinational Clinical Trials: Outcomes Reported from the Viewpoint of the Clinician, Patient, and Caregiver from October 26-27, 2009 in New Orleans, LA.
Horsham, PA (Vocus) September 2, 2009 --The Drug Information Association (DIA) Study Endpoints Special Interest Area Community (SIAC) will host Measuring Study Endpoints in Multinational Clinical Trials: Outcomes Reported from the Viewpoint of the Clinician, Patient, and Caregiver from October 26-27, 2009 in New Orleans, LA.
Representatives from industry, FDA, and EMEA will convene to discuss the scientific and regulatory issues surrounding the use of study endpoints in support of medical product labeling claims. Sessions will discuss common principles for the development and validation of all study endpoint measures and the relationships between entry criteria and outcome measurement and between different types of endpoint measures. Specific sessions include:
- Defining Terms and Setting the Regulatory Context
- Models, Measures and Claims
- Evaluating and Demonstrating Content Validity
- Regulatory Perspective of Content Validity in Pediatric, Caregiver, and Clinician-Reported Outcomes
- Practical Considerations for Multinational Clinical Trials Defining a Research Agenda for Study Endpoint Measurement and Multinational Clinical Trials
"There has been significant discussion, but little consensus with respect to a common set of best practices applicable across all types of study endpoints in clinical trials," says Laurie Burke, MPH, Capt. USPHS, Director, Study Endpoints and Labeling, Office of New Drugs, CDER, FDA. "This conference brings together key stakeholders to discuss the conceptual, measurement, and practical issues regarding study endpoints when applied to product development."
Click here to register.
About the Drug Information Association (DIA):
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.
Read the full story at http://www.prweb.com/releases/2009/09/prweb2822344.htm.
Related medicine news :1
Copyright©2009 Vocus, Inc.
All rights reserved
. ABMS and NQF Convene Summit on Enhancing Physician Performance: Stakeholders Agree Board Certification Should Play Bigger Role in Healthcare Quality Improvement2
. Patient-Centered Primary Care Collaborative Stakeholders Come to Washington, DC for July Working Meeting3
. Key Stakeholders Convene Capitol Hill Symposium To Advance Convergence of Behavioral Economics and Healthcare4
. HIMSS Electronic Health Record Association Reaches Out to Key Stakeholders on Meaningful Use of Certified EHRs5
. Major Stakeholders in Health Reform Debate Call for Greater Focus on Disease Prevention and Management in Senate Finance Committees Policy Options Paper6
. Major Stakeholders in Health Reform Debate Call for Improvements in Scoring of Congressional Health Care Proposals7
. Patient-Centered Primary Care Collaborative Stakeholders Convene in Washington, DC for Working Meeting8
. Stakeholders and public should use 20 specific health indicators9
. Leading Government and Advocacy Stakeholders Engage in Public Health Dialogue on Improving Disposal of Unused Medications10
. Newly Formed Consortium to Combat Medical Fraud Announces National Agenda to Intensify Fight Against Health Care Fraud Goals: Collaboration Across Industries; Alignment of Resources; Increased Awareness Among Public and Private Stakeholders Including Fede11
. ADA Calls for All Stakeholders to Work Together to Help Medicaid